{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:10:03Z","timestamp":1694610603874},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1007\/bf03164857","type":"journal-article","created":{"date-parts":[[2009,9,26]],"date-time":"2009-09-26T05:53:57Z","timestamp":1253944437000},"page":"169-174","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel"],"prefix":"10.1007","volume":"13","author":[{"given":"Tomio","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Oriuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Milas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Edmund","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald A.","family":"Podoloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03164857_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-198916060-00001","volume":"16","author":"WE Evans","year":"1989","unstructured":"Evans WE, Relling MV. Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.Clin Pharmacokinet 16: 327\u2013336, 1989.","journal-title":"Clin Pharmacokinet"},{"key":"BF03164857_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00838937","volume":"22","author":"JL Moretti","year":"1995","unstructured":"Moretti JL, Caglar M, D-Cordobes M, Morere JF. Can nuclear medicine predict response to chemotherapy?Eur J Nucl Med 22: 97\u2013100, 1995.","journal-title":"Eur J Nucl Med"},{"key":"BF03164857_CR3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC. Paclitaxel (Taxol).New Engl J Med 332: 1004\u20131014, 1995.","journal-title":"New Engl J Med"},{"key":"BF03164857_CR4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","volume":"277","author":"PB Schiff","year":"1979","unstructured":"Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assemblyin vitro by taxol.Nature 277: 665\u2013667, 1979.","journal-title":"Nature"},{"key":"BF03164857_CR5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/83.24.1797-a","volume":"83","author":"FA Holmes","year":"1991","unstructured":"Holmes FA, Walters RS, Theriault RL, Forman AD, New-ton LK, Raber MN, et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.J Natl Cancer Inst 83: 1797\u20131805, 1991.","journal-title":"J Natl Cancer Inst"},{"key":"BF03164857_CR6","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1994.12.9.1748","volume":"12","author":"JT Thigpen","year":"1994","unstructured":"Thigpen JT, Blessing JA, Ball H, Hummel SJ, Barrett RJ. Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy. A Gynecological Oncology Group study.J Clin Oncol 12: 1748\u20131753, 1994.","journal-title":"J Clin Oncol"},{"key":"BF03164857_CR7","first-page":"1042","volume":"38","author":"C Li","year":"1997","unstructured":"Li C, Yu DF, Inoue T, Yang DJ, Tansey W, Liu CW, et al. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.J Nucl Med 38: 1042\u20131047, 1997.","journal-title":"J Nucl Med"},{"key":"BF03164857_CR8","first-page":"3506","volume":"54","author":"L Milas","year":"1994","unstructured":"Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.Cancer Res 54: 3506\u20133510, 1994.","journal-title":"Cancer Res"},{"key":"BF03164857_CR9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/jnci\/60.4.887","volume":"60","author":"HB Stone","year":"1978","unstructured":"Stone HB, Milas L. Modification of radiation response of murine tumors by misonidazole (Ro 07-0582), host immune capability, andCorynebacterium parvum.J Natl Cancer Inst 60: 887\u2013893, 1978.","journal-title":"J Natl Cancer Inst"},{"key":"BF03164857_CR10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2307\/3577946","volume":"127","author":"LC Stephens","year":"1991","unstructured":"Stephens LC, Ang KK, Shultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors.Radiat Res 127: 308\u2013316, 1991.","journal-title":"Radiat Res"},{"key":"BF03164857_CR11","first-page":"2118","volume":"32","author":"K Kubota","year":"1991","unstructured":"Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.J Nucl Med 32: 2118\u20132123, 1991.","journal-title":"J Nucl Med"},{"key":"BF03164857_CR12","first-page":"1655","volume":"32","author":"Y Ichiya","year":"1991","unstructured":"Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment of response to cancer therapy using fluorine-18-fluoro-deoxyglucose and positron emission tomography.J Nucl Med 32: 1655\u20131660, 1991.","journal-title":"J Nucl Med"},{"key":"BF03164857_CR13","first-page":"2124","volume":"32","author":"Y Sasaki","year":"1991","unstructured":"Sasaki Y. Monitoring tumor radiotherapy.J Nucl Med 32: 2124\u20132125, 1991.","journal-title":"J Nucl Med"},{"key":"BF03164857_CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/bjc.1991.27","volume":"63","author":"P Philip","year":"1991","unstructured":"Philip P, Bagshawe K, Searle F, Green AJ, Begent RHJ, Newlands ES, et al.In vivo uptake of131I-5-iodo-2-deoxyuridine by malignant tumors in man.Br J Cancer 63: 134\u2013135, 1991.","journal-title":"Br J Cancer"},{"key":"BF03164857_CR15","first-page":"1129","volume":"35","author":"EE Sapir","year":"1994","unstructured":"Sapir EE, Bettman L, Iosilevsky G, Milshtein D, Frenkel A, Kolodny GM, et al. SPECT quantification of cobalt-57-bleomycin to predict treatment response and outcome of patients with lung cancer.J Nucl Med 35: 1129\u20131133, 1994.","journal-title":"J Nucl Med"},{"key":"BF03164857_CR16","first-page":"2306","volume":"37","author":"J Shani","year":"1977","unstructured":"Shani J, Wolf W. A model for prediction of chemotherapy response to 5-fluorouracil based on the differential distribution of 5-[18F]fluorouracil in sensitive versus resistant lymphocytic leukemia in mice.Cancer Res 37: 2306\u20132308, 1977.","journal-title":"Cancer Res"},{"key":"BF03164857_CR17","first-page":"1","volume":"21","author":"D Young","year":"1982","unstructured":"Young D, Vine E, Ghanbarpour A, Shani J, Siesmen JK, Wolf W. Metastatic and distribution studies with radiolabeled 5-fluorouracil.J Nucl Med 21: 1\u20137, 1982.","journal-title":"J Nucl Med"},{"key":"BF03164857_CR18","first-page":"55","volume":"15","author":"SB Horwitz","year":"1993","unstructured":"Horwitz SB, Cohen D, Rao S, Ringel I, Shen H, Yang CH. Taxol: Mechanism of action and resistance.Monogr Natl Cancer Inst Monogr 15: 55\u201361, 1993.","journal-title":"Monogr Natl Cancer Inst Monogr"},{"key":"BF03164857_CR19","first-page":"3856","volume":"45","author":"SN Roy","year":"1985","unstructured":"Roy SN, Horwitz SB. A phosphoglycoprotein associated with taxol-resistance in J774.2 cells.Cancer Res 45: 3856\u20133863, 1985.","journal-title":"Cancer Res"},{"key":"BF03164857_CR20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0360-3016(97)89488-6","volume":"38","author":"Y Saito","year":"1997","unstructured":"Saito Y, Milross CG, Hittleman WN, Li D, Jibu T, Peters LJ, et al. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction.Int J Rad Oncol Biol Phys 38: 623\u2013631, 1997.","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"BF03164857_CR21","first-page":"545","volume":"33","author":"Y Fujibayashi","year":"1992","unstructured":"Fujibayashi Y, Takemura Y, Matsumoto K, Wada K, Yonekura Y, Konishi J, et al. High myocardial accumulation of radioiodinated digoxin derivatives: a possible Na,KATPase imaging agent.J Nucl Med 33: 545\u2013549, 1992.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03164857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03164857\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03164857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:52:05Z","timestamp":1558479125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03164857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["BF03164857"],"URL":"https:\/\/doi.org\/10.1007\/bf03164857","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}